We produce diagnostic self-tests for deadly infectious disease. We use deep biotechnology to detect biomarkers in saliva without laboratory equipment to reduce exposure to medical staff. Early detection is the best way to strengthen global efforts in eradicating deadly infectious diseases. We are partnering with leading health research organizations to produce self-diagnostic products. Our goal is to contain the spread of infectious diseases.
Our team of experienced scientists and business experts is specialized in infectious diseases, clinical diagnostics and bioorganic chemistry. We are in R&D stage developing a diagnostic biotechnology platform for infectious diseases that can reduce testing costs by 80%. We are headquartered in Denmark, one of the leading biotech hubs in the world, with development partners in Brazil and Germany.
.png){kind=small}
twitter.png){kind=small}
.png){kind=small}
